Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Sep 29, 2022 10:11pm
316 Views
Post# 34996601

RE:Theralase Insider Buying

RE:Theralase Insider Buying

I thought the same thing. Very well expressed Eoganacht.  One or more of the biggest catalysts to date may be coming before year end. Lets hope it pans out as in our wildest dreams.


Eoganacht wrote: I've got to say how impressed I am with the participation of Dr. Mandel, Roger and Kristina in the private placement. Dr. Mandel ponied up $25,000 and the Dumoulin-White/Hachey family invested $575,000. This trial is Theralase's double or nothing shake of the dice. If FDA approval of TLD1433 for the treatment of NMIBC is not forthcoming, IMHO, Theralase will no longer be a going concern.  All of that money from their own pockets will be gone. These people, like many of the posters on this board, are getting a bit long in the tooth to be hazarding that much money on a gamble that, if it fails, will deprive them of a future source of income. With so much riding on trial results they have chosen not to hedge their bets,

This action betokens a level of confidence in the success of the trial that should warm the hearts of all Theralase investors.

 

<< Previous
Bullboard Posts
Next >>